GAMIDA
Novartis buys another 2.5% in Israel's Gamida CellNovartis will not have rights or options to Gamida Cell products or technology under the terms of the agreement.- Ambuja Realty ties up with Israel coThis one’s a pretty interesting tie-up. Harshavardhan Neotia of Ambuja Realty Group has joined hands with Elbit Medical Imaging of Israel t...
- Load More